Paige Review

Paige is an AI-driven digital pathology company that develops software tools to assist pathologists in analyzing whole slide images (WSIs) for cancer detection and diagnosis. The platform applies deep learning algorithms trained on extensive repositories of annotated pathology data to help identify areas of concern in tissue samples, with a focus on improving diagnostic accuracy and workflow efficiency in clinical environments. The company's flagship product, Paige Prostate, was the first FDA-authorized AI product for use in surgical pathology, designed to help pathologists detect prostate cancer in biopsy slides. Paige has since expanded its portfolio to include tools targeting other cancer types and diagnostic workflows, positioning itself as a comprehensive AI solution for anatomic pathology labs. Paige is primarily aimed at pathologists, health systems, academic medical centers, and reference laboratories seeking to integrate AI assistance into their diagnostic workflows. The software works alongside existing digital pathology infrastructure, including whole slide image scanners and laboratory information systems, rather than replacing existing processes. In the broader digital pathology market, Paige competes with other AI-assisted pathology platforms and traditional image analysis tools. Its FDA authorization distinguishes it from many research-only tools, as it is cleared for use in clinical decision support. The company has partnerships with major healthcare institutions and pathology equipment manufacturers to expand adoption. Pricing and deployment terms for Paige are typically negotiated directly with healthcare institutions and are not publicly listed, reflecting the enterprise and clinical nature of the product. Organizations interested in the platform would engage with Paige's sales team for evaluation and implementation details.